Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Price updated todayFinancials updated Oct 23, 2026
Explore stock sections · swipe left or right
DLHC · Price history
Price at last available close
$3.64
+$0.18 (+5.20%) 1M
2026-10-27
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Primary reporting period: 2025-09-30 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
DLH Holdings Corp., headquartered in Atlanta, Georgia, was established in 1969 and operated as TeamStaff, Inc. until its name change in June 2012. The company specializes in offering a range of technology-enabled business process outsourcing, comprehensive program management solutions, and public health research and analytics services throughout the United States, with a primary focus on the federal health services market. A significant portion of DLH's work involves defense and veterans' health, where it delivers integrated healthcare, technology, and logistical support.
How they make money
DLH Holdings Corp. provides technology-enabled business process outsourcing, program management, and health and readiness solutions primarily to federal government agencies. The company generates revenue through long-term government contracts, operating on a cost-plus-fixed-fee, time-and-materials, or firm-fixed-price basis, where it manages complex programs and delivers specialized professional services.
Products & services
Digital transformation, cybersecurity, systems engineering, integration, and science research and development services for federal health and defense agencies.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
For the fiscal year ended September 30, 2025, the Department of Veterans Affairs, the Department of Health and Human Services, and the Department of Defense collectively accounted for a significant portion of the company's total revenue.
Suppliers, materials & equipment
Subcontractors and independent consultants — The company utilizes various subcontractors and independent consultants to provide specialized technical expertise and support for its government contract obligations.Source
Strengths
Extensive experience in federal health and defense marketsSource
Strong portfolio of long-term government contractsSource
Risks
Dependence on government contracts and federal budget appropriationsSource
Risks associated with contract bidding and competitive procurement processesSource
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-06-30.
Quarterly revenue fell 46.9% versus the same quarter last year.
Check comparable business scope and currency, then separate volume, pricing and divestitures. One weaker quarter does not establish that the same decline will continue.
Quarterly EPS turned negative at -1.17 versus 0.02 a year earlier.
Separate recurring operating losses from noncash or one-time charges, and check cash flow rather than interpreting negative EPS as a cash-outflow amount.
Quarterly net income turned from a profit to a loss versus the same quarter last year.
Identify the causes in the interim report and distinguish operating cash use from accounting charges. Prior profitability is not a guarantee of recovery.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
26
Poor
PoorElite
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
39
Poor
Financial Strength
58
Business Quality / Moat
49
Management
26
Growth Quality
2
Risk / Durability
42
Weak Company · Expensive Stock
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
19
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
24/100
Building Historical Record
Model Score 24/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
What we like
•Balance-sheet / debt profile scores strongly
What to watch
•Debt service risk
•Valuation is a weaker part of the current profile
•Revenue fundamentals are weak
Company-specific research
Questions worth answering for DLHC
Research inputs 100% complete
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•What is driving DLHC's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
•Is DLHC's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
•Is DLHC's debt load manageable relative to cash generation, interest costs and upcoming maturities?
•What specifically needs to improve for DLHC to reach sustainable profitability?
•What future growth or profitability would be needed to justify DLHC's current valuation?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for DLHC
Detected from reported data — verify before acting.
Debt service risk
Interest coverage is low (~1.1x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)
No personal call yet on DLHC.
Potential upside factors
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Extensive experience in federal health and defense markets.
+Strong portfolio of long-term government contracts.
+Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
−Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Specialty Business Services industry.
−Dependence on government contracts and federal budget appropriations.
−Risks associated with contract bidding and competitive procurement processes.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Wall Street Score
Weak26/ 100
Weak (0–50)Fair (51–71)Strong (72+)
Debt
Strong
77
Debt Cost10.4%
Debt Reduction YoY12.0%
Debt / Equity1.28x
Tap for breakdown →
Revenue
Poor
20
Revenue YoY-26.4%
Revenue CAGR-4.3%
Net Margin-8.5%
Tap for breakdown →
Asset
Fair
55
Asset Growth YoY-7.5%
Liquidation/Share$6.45
Net Assets/MCap2.18x
Tap for breakdown →
Capital
Poor
0
Earnings Yield-41.3%
Buyback Yield0.0%
Debt Cost10.4%
Tap for breakdown →
Management
Poor
26
ROIC5.6%
ROE-23.1%
ROA-8.5%
Tap for breakdown →
Moat
Weak
49
EPS Growth-40.1%
FCF/Share Growth62.2%
Rev/Share Growth3.3%
Tap for breakdown →
Valuation
Poor
0
Intrinsic Value—
Value Reference—
MOS—
Tap for breakdown →
Buffett
Weak
43
Revenue20
Moat49
Valuation0
Tap for breakdown →
MOS
Poor
0
MOS %—
Value Reference—
Deep Discount Reference—
Tap for breakdown →
Financial
Poor
14
Interest Coverage1.1x
ROIC5.6%
FCF Yield44.0%
Tap for breakdown →
Master
Poor
16
Financial14
Valuation0
Debt77
Tap for breakdown →
Resilience
Poor
31
Survival Years0.2 yrs
Current Ratio1.00x
FCF Margin6.7%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
7 historical score records available
Previous Score
26
Oct 1, 2026
Change
Unchanged
Current Score
26
Oct 23, 2026
Category Changes
Revenue0
Debt0
Assets0
Capital0
Management0
Moat0
Valuation0
Buffett0
DLHC score was unchanged.
Projected Score
Projected Score
16
Projected Change
-9.6 points
Preliminary comparable-period financial changes suggest decline of approximately 9.6 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailable
Current Price
$3.64
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Value Reference: —
Deep Discount Reference: —
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Monetary values in USD. Share counts in raw units.
Income StatementBalance SheetCash Flow
AnnualQuarterlyTTM + Annual
All rows
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
Line Item
TTM
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
$253.5M
$344.5M
$395.9M
$375.9M
····
····
····
····
····
····
····
Cost of Revenue
$212.3M
$279.3M
$318.4M
$296.0M
····
····
····
····
····
····
····
Gross Profit
$41.2M
$65.2M
$77.5M
$79.9M
····
····
····
····
····
····
····
Research & Development
$0.00
$0.00
$0.00
$0.00
····
····
····
····
····
····
····
SG&A Expenses
$28.9M
$31.2M
$35.5M
$37.8M
····
····
····
····
····
····
····
Operating Expenses
$41.5M
$48.4M
$52.6M
$62.8M
····
····
····
····
····
····
····
EBITDA
$15.0M
$32.3M
$40.2M
$30.5M
····
····
····
····
····
····
····
Operating Income
-$271K
$16.8M
$24.9M
$17.1M
····
····
····
····
····
····
····
Interest Expense
$12.7M
$15.1M
$17.2M
$16.3M
····
····
····
····
····
····
····
Income Before Tax
-$13.4M
$1.8M
$7.7M
$820K
····
····
····
····
····
····
····
Income Tax Expense
$8.2M
$393K
$350K
-$641K
····
····
····
····
····
····
····
Net Income
-$21.6M
$1.4M
$7.4M
$1.5M
····
····
····
····
····
····
····
Basic EPS
$-1.51
$0.09
$0.52
$0.11
····
····
····
····
····
····
····
Basic Shares
14.39M
14.39M
14.17M
13.70M
····
····
····
····
····
····
····
Diluted Shares
14.39M
14.46M
14.40M
14.43M
····
····
····
····
····
····
····
Upgrade to Premium for up to 10 annual periods, where available.
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
Cash position grew
Debt reduced
What Weakened
Margins contracted
Potential Score Impact
Positive indicators included cash levels, debt levels. Pressure indicators included revenue growth, EPS growth, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 46.9%. EPS declined 5950.0%. Cash increased 21.1%. Total debt declined 9.5%. Net income margin declined by 38.3 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Upgrade to Premium to unlock all earnings history.View plans
Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.
Dividend HistoryShare
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Predictions & Historical PerformanceShare
Conservative Projected Values
3 Years
$———.——
Premium
5 Years
$———.——
Premium
10 Years
$———.——
Premium
Conservative Projection Rate
——%
Premium
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.